Complimentary Access to Hyperspace Search for Academic and Non-Profit Drug Discovery Research
To accelerate advancements in drug discovery, Alipheron provides academic and non-profit researchers with complimentary access to 𝗛𝘆𝗽𝗲𝗿𝘀𝗽𝗮𝗰𝗲 𝗦𝗲𝗮𝗿𝗰𝗵. …
News
Find all our news here.
DataWarrior v6.5 is released!
𝗗𝗮𝘁𝗮𝗪𝗮𝗿𝗿𝗶𝗼𝗿 𝘃𝟲.𝟱 𝗶𝘀 𝗿𝗲𝗹𝗲𝗮𝘀𝗲𝗱 𝘄𝗶𝘁𝗵 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 𝗮𝗻𝗱 𝗶𝗺𝗽𝗿𝗼𝘃𝗲𝗺𝗲𝗻𝘁𝘀! 𝗞𝗲𝘆 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 🧬 The quality of structures loaded from 𝗣𝗗𝗕 𝗳𝗶𝗹𝗲𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗣𝗗𝗕 …
Alipheron moved to Tech Park Stuecki in Basel
𝗔𝗹𝗶𝗽𝗵𝗲𝗿𝗼𝗻 𝗺𝗼𝘃𝗲𝗱 𝗶𝗻𝘁𝗼 𝗮 𝗻𝗲𝘄 𝗵𝗼𝗺𝗲! 🚀 ✅ During the summer holidays, Alipheron moved out of a garage in Dornach and into the thriving biotech start-up …
Ten DataWarrior Tricks You Might Not Know
DataWarrior is a powerful, open-source software primarily used in the life sciences for interactive data visualization and analysis, and with a strong …
New Website Launch
🎉 Exciting News: Alipheron Launches a Brand-New Website For You! 🌐🚀 We are excited to present a greatly expanded section on our Ultra-Large …
Query Features for Substructure and Similarity Searching
This post offers a concise look at query features, a powerful and practical concept boosting substructure and similarity searching in cheminformatics. …
DataWarrior Among Top Cheminformatics Solutions For Pharmaceutical Industry in 2025
An extensive analysis by IntuitionLabs established the Top 10 Open-Source Software Tools in the Pharmaceutical Industry in 2025. DataWarrior came out …
Alipheron will be Participating in 13th ICCS Netherlands 2025
Alipheron is excited to announce that we will be participating in the 13th International Conference on Chemical Structures (ICCS) from June 1-5 in the …
Join us at the ACS MEDI-EFMC meeting in Chicago next week!
Do you want to know how efficient hit expansion and scaffold hopping in ultra-large combinatorial spaces using Pharos3D within DataWarrior can provide …
PharmaBlock and Alipheron Launch Ultra-Large Combinatorial Library for Drug Discovery
We are pleased to announce a strategic collaboration between PharmaBlock Sciences and Alipheron AG, culminating in the creation of an ultra-large …
